Sociodemographic Characteristics of Women Able to Obtain Medication Abortion Before and After Ohio's Law Requiring Use of the Food and Drug Administration Protocol
- PMID: 30283858
- PMCID: PMC6071907
- DOI: 10.1089/heq.2018.0002
Sociodemographic Characteristics of Women Able to Obtain Medication Abortion Before and After Ohio's Law Requiring Use of the Food and Drug Administration Protocol
Abstract
Purpose: In 2011, a law went into effect in Ohio that regulates how abortion care providers can offer medication abortion to their patients. We sought to evaluate changes in sociodemographic characteristics of Ohio medication abortion patients before and after the implementation of this law. Methods: We used a retrospective cohort design, comparing characteristics of women obtaining a medication abortion at four abortion facilities before and after the law. We used chart data from January 2010 to January 2011 and February 2011 to October 2014. For any significant changes in sociodemographics found before and after the law, we used stratified cross-tabulations to disentangle whether they were likely related to the restricted gestational limit imposed by the law (lowered from 9 to 7 weeks gestation), or whether they were likely related to other burdens brought on by the law, such as increased costs and visits. Results: Women obtaining a medication abortion after the law were more likely to be older (p=0.01), have higher levels of education (p<0.001), be of white race (p<0.001), have private insurance (p=0.001), have no children (p=0.002), and reside in a higher income zip code (p=0.03). Both the reduced gestational limit and the increased costs and visits likely contributed to declines among black women and women with lower levels of education. The reduced gestational limit for medication abortion likely contributed to a decline among younger women and Medicaid recipient groups. The increased costs and visits imposed by the law likely contributed to the decline in medication abortion among women with no insurance and women with children. Conclusion: The lower gestational limit, higher cost, and time and travel burdens exacted by Ohio's medication abortion law were associated with disproportionate reductions in medication abortion among the most disadvantaged groups. The law was associated with reduced access among women who were younger, of black race, less educated, and in lower socioeconomic groups.
Keywords: Ohio; abortion; health policy; medication abortion; sociodemographic characteristics.
Conflict of interest statement
No competing financial interests exist.
Figures
Similar articles
-
Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.PLoS Med. 2016 Aug 30;13(8):e1002110. doi: 10.1371/journal.pmed.1002110. eCollection 2016 Aug. PLoS Med. 2016. PMID: 27575488 Free PMC article.
-
Medication abortion use among low-income and rural Texans before and during state-imposed restrictions and after FDA-updated labeling.Am J Obstet Gynecol. 2020 Aug;223(2):236.e1-236.e8. doi: 10.1016/j.ajog.2020.02.028. Epub 2020 Feb 25. Am J Obstet Gynecol. 2020. PMID: 32109462 Free PMC article.
-
Implications of Ohio's 20-Week Abortion Ban on Prenatal Patients and the Assessment of Fetal Anomalies.Obstet Gynecol. 2017 May;129(5):795-799. doi: 10.1097/AOG.0000000000001996. Obstet Gynecol. 2017. PMID: 28383385
-
The impact of Mississippi's mandatory delay law on abortions and births.JAMA. 1997 Aug 27;278(8):653-8. JAMA. 1997. PMID: 9272897
-
Implications for women of Louisiana's law requiring abortion providers to have hospital admitting privileges.Contraception. 2015 May;91(5):368-72. doi: 10.1016/j.contraception.2015.02.001. Epub 2015 Mar 2. Contraception. 2015. PMID: 25744615
Cited by
-
"I don't regret it at all. It's just I wish the process had a bit more humanity to it … a bit more holistic": a qualitative, community-led medication abortion study with Black and Latinx Women in Georgia, USA.Sex Reprod Health Matters. 2022 Dec;30(1):2129686. doi: 10.1080/26410397.2022.2129686. Sex Reprod Health Matters. 2022. PMID: 36368036 Free PMC article.
-
Abortion access and the US medical workforce: a looming crisis for haematology.Lancet Haematol. 2022 Dec;9(12):e874-e875. doi: 10.1016/S2352-3026(22)00324-6. Epub 2022 Oct 14. Lancet Haematol. 2022. PMID: 36244351 Free PMC article. No abstract available.
-
Racial/ethnic and educational inequities in restrictive abortion policy variation and adverse birth outcomes in the United States.BMC Health Serv Res. 2021 Oct 22;21(1):1139. doi: 10.1186/s12913-021-07165-x. BMC Health Serv Res. 2021. PMID: 34686197 Free PMC article.
-
Telehealth vs In-Clinic Medication Abortion Services.JAMA Netw Open. 2023 Sep 5;6(9):e2331900. doi: 10.1001/jamanetworkopen.2023.31900. JAMA Netw Open. 2023. PMID: 37656461 Free PMC article.
References
-
- Weitz TA, Foster A, Ellertson C, et al. . “Medical” and “surgical” abortion: rethinking the modifiers. Contraception. 2004;69:77–78 - PubMed
-
- Winikoff B, Westhoff C. Fifteen years: looking back and looking forward. Contraception. 2015;92:177–178 - PubMed
-
- Greene MF, Drazen JM. A new label for mifepristone. N Engl J Med. 2016;374:2281–2282 - PubMed
-
- Spitz IM, Bardin CW, Benton L, et al. . Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. 1998;338:1241–1247 - PubMed
-
- Raymond EG, Shannon C, Weaver MA, et al. . First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review. Contraception. 2013;87:26–37 - PubMed
LinkOut - more resources
Full Text Sources